Codiak BioSciences develops exosome-based therapeutics for various diseases, including oncology, neurology, neuromuscular diseases, and infectious diseases. Its leading products are exoSTING and exoIL-12 used to treat solid tumor. The company has a collaboration agreement with prominent companies and institutions, including Sarepta Therapeutics and Harvard.